Compare $ALLR vs $INTI | Chartloom

Compare

$ALLR vs $INTI

Allarity Therapeutics Inc · Inhibitor Therapeutics Inc

ALLR

Allarity Therapeutics Inc

INTI

Inhibitor Therapeutics Inc

Compare $ALLR vs $INTI

Comparing Allarity Therapeutics Inc and Inhibitor Therapeutics Inc

ALLRAllarity Therapeutics Inc

INTIInhibitor Therapeutics Inc

ALLRAllarity Therapeutics Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-13.2%

52W performance

-41.8%

FCF yield

-87.5%

INTIInhibitor Therapeutics Inc

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

108.5%

52W performance

127.9%

FCF yield

-19.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALLR

INTI

Detailed metrics comparison

ALLR

Allarity Therapeutics Inc

INTI

Inhibitor Therapeutics Inc

Market Cap

ALLR$16M

INTI$17M

Enterprise Value

ALLR$21M

INTI$16M

Price

ALLR$0.99

INTI$0.10

P/E Ratio

ALLRN/A

INTIN/A

P/S Ratio

ALLR45.65x

INTI4.25x

EV/Sales

ALLR61.03x

INTI4.12x

EV/EBITDA

ALLR0.00x

INTI1.61x

P/B Ratio

ALLR4.68x

INTI4,922.43x

P/FCF Ratio

ALLRN/A

INTIN/A

EV/FCF

ALLR-1.53x

INTI-5.09x

PEG Ratio

ALLRN/A

INTIN/A

Forward P/E (NTM)

ALLRN/A

INTIN/A

Forward P/S (NTM)

ALLRN/A

INTIN/A

Revenue (TTM)

ALLR$345K

INTI$0

Revenue Growth (YoY)

ALLRN/A

INTIN/A

Forward Rev Growth

ALLR0.0%

INTI0.0%

Gross Margin (TTM)

ALLR0.0%

INTI20.9%

Operating Margin (TTM)

ALLR0.0%

INTI0.0%

EBITDA Margin (TTM)

ALLR-771.9%

INTI0.0%

Net Margin (TTM)

ALLR-3575.1%

INTI0.0%

FCF Margin (TTM)

ALLR-3994.8%

INTIN/A

Net Income (TTM)

ALLR$-12M

INTI$-3M

FCF (TTM)

ALLR$-14M

INTI$-3M

EPS (TTM)

ALLR-$0.78

INTI$0.00

ROE (TTM)

ALLR-15277.0%

INTI-33792.0%

ROA (TTM)

ALLR-4650.0%

INTI-12210.0%

ROIC (TTM)

ALLR-6256.0%

INTI-33792.0%

Cash

ALLR$17M

INTI$516K

Debt

ALLR$22M

INTI$0

Net Cash/Debt

ALLR$-5M

INTI$516K

Current Ratio (TTM)

ALLR1.11x

INTI3.36x

Quick Ratio (TTM)

ALLR0.99x

INTI2.95x

Debt/Equity (TTM)

ALLR6.30x

INTI0.00x

Debt/Assets (TTM)

ALLR0.0%

INTI0.0%

Interest Coverage (TTM)

ALLRN/A

INTIN/A

Net Debt/EBITDA (TTM)

ALLR0.00x

INTI0.00x

Beta

ALLR0.60

INTI-0.79

52W Performance

ALLR-41.8%

INTI127.9%

YTD Performance

ALLR-13.2%

INTI108.5%

% from 52W High

ALLR-46.2%

INTI-21.0%

% from 52W Low

ALLR28.6%

INTI180.0%

Asset Turnover (TTM)

ALLR0.00x

INTI0.50x

FCF Yield (TTM)

ALLR-87.5%

INTI-19.1%

Earnings Yield (TTM)

ALLR-78.3%

INTI-15.9%

Dividend Yield (TTM)

ALLRN/A

INTIN/A

Rule of 40

ALLR-3,994.8

INTI0.0

EV/GP/RG

ALLRN/A

INTIN/A

Ticker research

View ALLR research View INTI research

Metric	ALLR Allarity Therapeutics Inc	INTI Inhibitor Therapeutics Inc
Market & Valuation
Market Cap	$16M	$17M
Enterprise Value	$21M	$16M
Price	$0.99	$0.10
P/E Ratio	N/A	N/A
P/S Ratio	45.65x	4.25x
EV/Sales	61.03x	4.12x
EV/EBITDA	0.00x	1.61x
P/B Ratio	4.68x	4,922.43x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	-5.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$345K	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	20.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-771.9%	0.0%
Net Margin (TTM)	-3575.1%	0.0%
FCF Margin (TTM)	-3994.8%	N/A
Net Income (TTM)	$-12M	$-3M
FCF (TTM)	$-14M	$-3M
EPS (TTM)	-$0.78	$0.00
ROE (TTM)	-15277.0%	-33792.0%
ROA (TTM)	-4650.0%	-12210.0%
ROIC (TTM)	-6256.0%	-33792.0%
Financial Health
Cash	$17M	$516K
Debt	$22M	$0
Net Cash/Debt	$-5M	$516K
Current Ratio (TTM)	1.11x	3.36x
Quick Ratio (TTM)	0.99x	2.95x
Debt/Equity (TTM)	6.30x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	-0.79
52W Performance	-41.8%	127.9%
YTD Performance	-13.2%	108.5%
% from 52W High	-46.2%	-21.0%
% from 52W Low	28.6%	180.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.50x
FCF Yield (TTM)	-87.5%	-19.1%
Earnings Yield (TTM)	-78.3%	-15.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,994.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALLR research	View INTI research

Valuation

P/S Ratio

INTI

4.25x

ALLR

45.65x

EV/FCF

INTI

-5.09x

ALLR

-1.53x

Growth & revenue

Forward Revenue Growth

ALLR

0.0%

INTI

0.0%

Profitability & performance

Gross Margin

INTI

20.9%

ALLR

0.0%

ROE

ALLR

-15277.0%

INTI

-33792.0%

FCF Yield %

INTI

-19.1%

ALLR

-87.5%

52-Week Performance

INTI

127.9%

ALLR

-41.8%

Detailed metrics comparison

ALLR

Allarity Therapeutics Inc

INTI

Inhibitor Therapeutics Inc

Market Cap

ALLR$16M

INTI$17M

Enterprise Value

ALLR$21M

INTI$16M

Price

ALLR$0.99

INTI$0.10

P/E Ratio

ALLRN/A

INTIN/A

P/S Ratio

ALLR45.65x

INTI4.25x

EV/Sales

ALLR61.03x

INTI4.12x

EV/EBITDA

ALLR0.00x

INTI1.61x

P/B Ratio

ALLR4.68x

INTI4,922.43x

P/FCF Ratio

ALLRN/A

INTIN/A

EV/FCF

ALLR-1.53x

INTI-5.09x

PEG Ratio

ALLRN/A

INTIN/A

Forward P/E (NTM)

ALLRN/A

INTIN/A

Forward P/S (NTM)

ALLRN/A

INTIN/A

Revenue (TTM)

ALLR$345K

INTI$0

Revenue Growth (YoY)

ALLRN/A

INTIN/A

Forward Rev Growth

ALLR0.0%

INTI0.0%

Gross Margin (TTM)

ALLR0.0%

INTI20.9%

Operating Margin (TTM)

ALLR0.0%

INTI0.0%

EBITDA Margin (TTM)

ALLR-771.9%

INTI0.0%

Net Margin (TTM)

ALLR-3575.1%

INTI0.0%

FCF Margin (TTM)

ALLR-3994.8%

INTIN/A

Net Income (TTM)

ALLR$-12M

INTI$-3M

FCF (TTM)

ALLR$-14M

INTI$-3M

EPS (TTM)

ALLR-$0.78

INTI$0.00

ROE (TTM)

ALLR-15277.0%

INTI-33792.0%

ROA (TTM)

ALLR-4650.0%

INTI-12210.0%

ROIC (TTM)

ALLR-6256.0%

INTI-33792.0%

Cash

ALLR$17M

INTI$516K

Debt

ALLR$22M

INTI$0

Net Cash/Debt

ALLR$-5M

INTI$516K

Current Ratio (TTM)

ALLR1.11x

INTI3.36x

Quick Ratio (TTM)

ALLR0.99x

INTI2.95x

Debt/Equity (TTM)

ALLR6.30x

INTI0.00x

Debt/Assets (TTM)

ALLR0.0%

INTI0.0%

Interest Coverage (TTM)

ALLRN/A

INTIN/A

Net Debt/EBITDA (TTM)

ALLR0.00x

INTI0.00x

Beta

ALLR0.60

INTI-0.79

52W Performance

ALLR-41.8%

INTI127.9%

YTD Performance

ALLR-13.2%

INTI108.5%

% from 52W High

ALLR-46.2%

INTI-21.0%

% from 52W Low

ALLR28.6%

INTI180.0%

Asset Turnover (TTM)

ALLR0.00x

INTI0.50x

FCF Yield (TTM)

ALLR-87.5%

INTI-19.1%

Earnings Yield (TTM)

ALLR-78.3%

INTI-15.9%

Dividend Yield (TTM)

ALLRN/A

INTIN/A

Rule of 40

ALLR-3,994.8

INTI0.0

EV/GP/RG

ALLRN/A

INTIN/A

Ticker research

View ALLR research View INTI research

Metric	ALLR Allarity Therapeutics Inc	INTI Inhibitor Therapeutics Inc
Market & Valuation
Market Cap	$16M	$17M
Enterprise Value	$21M	$16M
Price	$0.99	$0.10
P/E Ratio	N/A	N/A
P/S Ratio	45.65x	4.25x
EV/Sales	61.03x	4.12x
EV/EBITDA	0.00x	1.61x
P/B Ratio	4.68x	4,922.43x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	-5.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$345K	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	20.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-771.9%	0.0%
Net Margin (TTM)	-3575.1%	0.0%
FCF Margin (TTM)	-3994.8%	N/A
Net Income (TTM)	$-12M	$-3M
FCF (TTM)	$-14M	$-3M
EPS (TTM)	-$0.78	$0.00
ROE (TTM)	-15277.0%	-33792.0%
ROA (TTM)	-4650.0%	-12210.0%
ROIC (TTM)	-6256.0%	-33792.0%
Financial Health
Cash	$17M	$516K
Debt	$22M	$0
Net Cash/Debt	$-5M	$516K
Current Ratio (TTM)	1.11x	3.36x
Quick Ratio (TTM)	0.99x	2.95x
Debt/Equity (TTM)	6.30x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	-0.79
52W Performance	-41.8%	127.9%
YTD Performance	-13.2%	108.5%
% from 52W High	-46.2%	-21.0%
% from 52W Low	28.6%	180.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.50x
FCF Yield (TTM)	-87.5%	-19.1%
Earnings Yield (TTM)	-78.3%	-15.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,994.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALLR research	View INTI research